{
  "question_stem": {
    "en": "7A 2-year-old man is brought to the hospital due to severe substernal chest pain and shortness of breath for the last several hours. The pain started suddenly when he was outside working in the garden. Medical history includes diet-controlled diabetes mellitus and hypertension. Physical examination reveals bilateral crackles and a third heart sound. ECG shows ST elevation in multiple leads. The patient is diagnosed with an acute myocardial infarction complicated by acute severe heart failure. He is started on dobutamine infusion and prepared for coronary catheterization. Which of the following is most likely to be increased due to the medication used in this patient?",
    "zh": "一名2岁男性因严重胸骨下疼痛和呼吸急促在过去几个小时内被送往医院。 疼痛突然开始于他在花园里工作时。 病史包括饮食控制的糖尿病和高血压。 体格检查显示双侧啰音和第三心音。 心电图显示多导联ST段抬高。 患者被诊断为急性心肌梗死，伴有急性严重心力衰竭。 他开始静脉输注多巴酚丁胺，并准备进行冠状动脉导管插入术。 由于该患者使用的药物，以下哪项最有可能增加？"
  },
  "question": {
    "en": "Which of the following is most likely to be increased due to the medication used in this patient?",
    "zh": "由于该患者使用的药物，以下哪项最有可能增加？"
  },
  "options": {
    "A": {
      "en": "Cardiac diastolic filling time",
      "zh": "心脏舒张充盈时间"
    },
    "B": {
      "en": "Myocardial oxygen consumption",
      "zh": "心肌耗氧量"
    },
    "C": {
      "en": "Peripheral vascular resistance",
      "zh": "外周血管阻力"
    },
    "D": {
      "en": "Pulmonary capillary wedge pressure",
      "zh": "肺毛细血管楔压"
    },
    "E": {
      "en": "Right ventricular end diastolic pressure",
      "zh": "右心室舒张末期压力"
    }
  },
  "correct_answer": "B",
  "explanation": {
    "en": "Dobutamine pharmacology {{exhibit_1}}\n\nDobutamine is a beta adrenergic agonist with predominant activity on beta-1 receptors, weaker activity on beta-2 receptors, and minimal activity on alpha-1 receptors. It is used for management of refractory heart failure associated with severe left ventricular systolic dysfunction and cardiogenic shock. Stimulation of beta adrenergic receptors results in increased production of cAMP in target cells and causes the following effects:\n\n*   Positive inotropy and chronotropy: Increased cardiac contractility (potent effect) and heart rate (weaker effect), leading to increased cardiac output (improves end-organ perfusion) and decreased left ventricular filling pressures (improves pulmonary congestion/edema)\n*   Mild vasodilation: Decreased systemic vascular resistance that often causes a slight reduction in blood pressure; this avoids the increase in afterload seen with other vasopressor/inotropic agents (eg, norepinephrine) but limits its usefulness in severely hypotensive patients\n\nThe strong inotropic effect of dobutamine significantly increases myocardial oxygen consumption, which can trigger or exacerbate myocardial ischemia. As such, dobutamine should not be used routinely in patients with decompensated heart failure. However, in patients with cardiogenic shock, this drawback is often outweighed by improvement in cardiac output and end-organ perfusion.\n\n(Choice A) Dobutamine is a weak chronotropic agent that causes an increase in heart rate. This leads to a decrease in cardiac diastolic filling time.\n\n(Choice C) In the vasculature, the beta-2 agonist effects (vasodilation) of dobutamine are somewhat stronger than its alpha-1 agonist activity (vasoconstriction), resulting in overall mild vasodilation. The net hemodynamic effects are a decrease in systemic vascular resistance with or without a slight reduction in blood pressure.\n\n(Choices D and E) Dobutamine causes decreased pulmonary capillary wedge pressure and left and right ventricular filling pressures due to the increased cardiac contractility and output.\n\nEducational objective:\nDobutamine is a beta adrenergic agonist with predominant activity on beta-1 receptors. It causes an increase in heart rate and cardiac contractility, leading to an increase in myocardial oxygen consumption. {{exhibit_2}}",
    "zh": "多巴酚丁胺药理学 {{exhibit_1}}\n\n多巴酚丁胺是一种β肾上腺素能受体激动剂，主要作用于β-1受体，对β-2受体的活性较弱，对α-1受体的活性最小。 它用于治疗与严重左心室收缩功能障碍和心源性休克相关的难治性心力衰竭。 刺激β肾上腺素能受体导致靶细胞中cAMP的产生增加，并引起以下作用：\n\n*   正性肌力和正性变时性：增加心肌收缩力（强大作用）和心率（较弱作用），导致心输出量增加（改善终末器官灌注）和左心室充盈压降低（改善肺充血/水肿）\n*   轻度血管舒张：全身血管阻力降低，通常会导致血压略有下降； 这避免了与其他血管加压药/正性肌力药（例如去甲肾上腺素）相关的后负荷增加，但限制了其在严重低血压患者中的应用\n\n多巴酚丁胺的强大正性肌力作用显着增加心肌耗氧量，这可能引发或加剧心肌缺血。 因此，多巴酚丁胺不应常规用于失代偿性心力衰竭患者。 然而，在心源性休克患者中，这种缺点通常被心输出量和终末器官灌注的改善所抵消。\n\n（选项A）多巴酚丁胺是一种弱正性变时性药物，可引起心率增加。 这会导致心脏舒张充盈时间减少。\n\n（选项C）在血管系统中，多巴酚丁胺的β-2激动剂效应（血管舒张）比其α-1激动剂活性（血管收缩）略强，导致总体轻度血管舒张。 净血流动力学效应是全身血管阻力降低，并伴有或不伴有血压略有下降。\n\n（选项D和E）由于心肌收缩力和输出量的增加，多巴酚丁胺导致肺毛细血管楔压以及左、右心室充盈压降低。\n\n教育目标：\n多巴酚丁胺是一种β肾上腺素能受体激动剂，主要作用于β-1受体。 它引起心率和心肌收缩力增加，从而导致心肌耗氧量增加。 {{exhibit_2}}"
  },
  "summary": {
    "en": "This question tests knowledge of dobutamine pharmacology and its effects on myocardial oxygen consumption. It also assesses understanding of the hemodynamic effects of dobutamine in the context of acute myocardial infarction and heart failure. \n\nThe key to solving this question is recognizing that dobutamine, while improving cardiac output, also increases myocardial oxygen demand due to its inotropic and chronotropic effects. Understanding the receptor-specific actions of dobutamine helps differentiate it from other inotropic agents.",
    "zh": "这个问题测试了对多巴酚丁胺药理学及其对心肌耗氧量的影响的了解。 它还评估了对多巴酚丁胺在急性心肌梗死和心力衰竭背景下的血流动力学效应的理解。 \n\n解决这个问题的关键是认识到多巴酚丁胺在改善心输出量的同时，也会由于其正性肌力和正性变时性作用而增加心肌耗氧量。 了解多巴酚丁胺的受体特异性作用有助于将其与其他正性肌力药区分开来。"
  },
  "tags": "Dobutamine; Myocardial oxygen consumption; Acute myocardial infarction; Heart failure; Beta-adrenergic agonists; Inotropic agents; Cardiology; Pharmacology",
  "category": "CVS",
  "question_id": "1344",
  "has_exhibits": true,
  "exhibit_count": 2,
  "exhibit_files": [
    "image1.jpg",
    "image2.jpg"
  ],
  "folder_path": "C:\\Datas\\usmle\\step1\\clip\\CVS 23\\1344",
  "extracted_at": "2025-11-05T11:53:10.858533",
  "extraction_config": {
    "temperature": 0.1,
    "top_k": 1,
    "prompt_strategy": "standard"
  },
  "translated_at": "2025-11-07T16:45:00.546213",
  "translation_model": "gemini-2.0-flash-lite",
  "embedding_model": "models/embedding-001",
  "embedding_dimension": 768
}